# Trimetazidine as an Adjunct to Enhance Clopidogrel Response.

> **NCT03603249** · PHASE2 · COMPLETED · sponsor: **The University of The West Indies** · enrollment: 24 (actual)

## Conditions studied

- Platelet Dysfunction Due to Drugs

## Interventions

- **DRUG:** Trimetazidine

## Key facts

- **NCT ID:** NCT03603249
- **Lead sponsor:** The University of The West Indies
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603249, "Trimetazidine as an Adjunct to Enhance Clopidogrel Response.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03603249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*